Truveta’s Post

View organization page for Truveta, graphic

74,631 followers

In partnership with University of Pennsylvania Perelman School of Medicine Vice Provost Dr. Ezekiel Emanuel, MD, PhD, Truveta Research conducted the first-ever study on whether patients taking GLP-1s like semaglutide and tirzepatide showed trends of discontinuing and reinitiating these meds. Now available as a preprint on MedRxiv: https://tr.vet/3YM0q1X #PrePrint #PennMedical #PennMedicalResearch #GLP1Research #WeightLossDrugs #WeightLoss #Semaglutide #Tirzepatide #Wegovy #Ozempic #Mounjaro #Zepbound #HealthData #PrescriptionTrends #AI #Innovation #HealthAI #HealthInnovation #HealthTech #HealthcareData #HealthcareTech #MedicalTechnology #MedicalData #MedTech #PrePrint #MedicalResearch #HealthResearch #PrescriptionTrends

MedRxiv: Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity

MedRxiv: Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity

medrxiv.org

Hello Truveta Team, I recently received a job offer for a Frontend Developer position from someone named Deb Nielsen, who contacted me through Microsoft Teams. I wanted to verify if this offer is genuine. Could you please confirm whether this recruitment is official? Thank you for your assistance.

Like
Reply

To view or add a comment, sign in

Explore topics